Kopran Limited (BOM:524280)
India · Delayed Price · Currency is INR 261.45
-3.45 (-1.30%)
At close: Nov 6, 2026
Kopran Market Cap
Kopran has a market cap or net worth of 12.62 billion as of November 6, 2026. It is the 22,900th most valuable company in the world and the 1,481st biggest in India. Its market cap has increased by 58.84% in one year.
Market Cap
12.62B
Enterprise Value
14.63B
Revenue
7.94B
Global Rank
Country Rank
#1,481 India
PE Ratio
32.05
ChartMarket Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 12.62B, an increase of 2,107.04%. That is a compound annual growth rate of 13.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 12.62B | 74.42% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syncom Formulations (India) | 17.94B |
| Venus Remedies | 17.63B |
| Amrutanjan Health Care | 14.44B |
| Bharat Parenterals | 13.17B |
| TTK Healthcare | 12.94B |
| Fermenta Biotech | 12.26B |
| Lincoln Pharmaceuticals | 10.10B |
| Sudarshan Pharma Industries | 8.27B |